Research from Icahn School of Medicine at Mount Sinai in Crohn's Disease Provides New Insights (Risankizumab Induction Therapy Achieves Early Symptom Improvements That Are Associated With Future Clinical and Endoscopic Outcomes in Crohn's ...)

Media coverage

• Title	Research from Icahn School of Medicine at Mount Sinai in Crohn's Disease Provides New Insights (Risankizumab Induction Therapy Achieves Early Symptom Improvements That Are Associated With Future Clinical and Endoscopic Outcomes in Crohn's ...)
  Media name/outlet	Immunotherapy Daily
  Country/Territory	United States
  Date	22/12/23
  Persons	Marla Dubinsky